LA
TRLV

Lynch & Associates’s Trulieve Cannabis Corp TRLV Stock Holding History

Lynch & Associates’s Portfolio TRLV Stock Details TRLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,500
Closed -$205K – 107
2021
Q1 		$205K Buy
+4,500
New +$205K 0.06% 99

Other funds holding TRLV

ADMI
Albert D. Mason Inc Boston, Massachusetts $176M AUM 40.3% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
GG
Gofen & Glossberg Chicago, Illinois $3.89B AUM 11.97% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
HWA
Heritage Wealth Advisors Richmond, Virginia $2.91B AUM 24.25% 1-Year Est. Return
HCM
Horrell Capital Management Little Rock, Arkansas $219M AUM 21.7% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Lynch & Associates's TRLV Position: Q2 2021 in Review

Lynch & Associates sold out of Trulieve Cannabis Corp (TRLV) in Q2 2021, closing a stake of 4,500 shares — an estimated $205K sold.

Lynch & Associates first reported a position in TRLV in Q1 2021 and held it in 1 quarter. The position peaked at $205K in Q1 2021. 8 funds tracked by Wall St. Rank hold TRLV as of Q2 2021.

  • Lynch & Associates reported no remaining Trulieve Cannabis Corp position as of Q2 2021 after selling out during the quarter.
  • Lynch & Associates sold 4,500 Trulieve Cannabis Corp shares in Q2 2021, an estimated $205K.
  • Lynch & Associates first reported a position in Trulieve Cannabis Corp in Q1 2021 and held it in 1 quarter.
  • Lynch & Associates's Trulieve Cannabis Corp position peaked at $205K in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Trulieve Cannabis Corp as of Q2 2021.

Based on Lynch & Associates's 13F filing for Q2 2021, filed 21 Jul 2021.